Sulpiride‐induced tardive dystonia
Identifieur interne : 009606 ( Main/Merge ); précédent : 009605; suivant : 009607Sulpiride‐induced tardive dystonia
Auteurs : Lucinda G. Miller [États-Unis] ; Jankovic [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1990.
English descriptors
- KwdEn :
- Adult, Antipsychotic Agents (adverse effects), Antipsychotic Agents (therapeutic use), Dyskinesia, Drug-Induced (etiology), Dystonia (chemically induced), Humans, Male, Parkinsonism, Psychotic Disorders (drug therapy), Receptors, Dopamine (drug effects), Receptors, Dopamine D2, Sulpiride, Sulpiride (adverse effects), Sulpiride (therapeutic use), Tardive dystonia.
- MESH :
- chemical , adverse effects : Antipsychotic Agents, Sulpiride.
- chemical , drug effects : Receptors, Dopamine.
- chemical , therapeutic use : Antipsychotic Agents, Sulpiride.
- chemically induced : Dystonia.
- drug therapy : Psychotic Disorders.
- etiology : Dyskinesia, Drug-Induced.
- Adult, Humans, Male, Receptors, Dopamine D2.
Abstract
Sulpiride is a selective D2‐receptor antagonist with antipsychotic and antidepressant properties. Although initially thought to be free of extrapyramidal side effects, sulpiride‐induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a 37‐year‐old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not find any previous reports of sulpiride‐induced tardive dystonia.
Url:
DOI: 10.1002/mds.870050119
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003B72
- to stream Istex, to step Curation: 003B72
- to stream Istex, to step Checkpoint: 004361
- to stream PubMed, to step Corpus: 004F45
- to stream PubMed, to step Curation: 004F45
- to stream PubMed, to step Checkpoint: 004E75
- to stream Ncbi, to step Merge: 002784
- to stream Ncbi, to step Curation: 002784
- to stream Ncbi, to step Checkpoint: 002784
Links to Exploration step
ISTEX:F419D35E0DD2E2934DEA8404678245319EF21ED2Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sulpiride‐induced tardive dystonia</title>
<author><name sortKey="Miller, Lucinda G" sort="Miller, Lucinda G" uniqKey="Miller L" first="Lucinda G." last="Miller">Lucinda G. Miller</name>
</author>
<author><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F419D35E0DD2E2934DEA8404678245319EF21ED2</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1002/mds.870050119</idno>
<idno type="url">https://api.istex.fr/document/F419D35E0DD2E2934DEA8404678245319EF21ED2/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003B72</idno>
<idno type="wicri:Area/Istex/Curation">003B72</idno>
<idno type="wicri:Area/Istex/Checkpoint">004361</idno>
<idno type="wicri:doubleKey">0885-3185:1990:Miller L:sulpiride:induced:tardive</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:1967484</idno>
<idno type="wicri:Area/PubMed/Corpus">004F45</idno>
<idno type="wicri:Area/PubMed/Curation">004F45</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004E75</idno>
<idno type="wicri:Area/Ncbi/Merge">002784</idno>
<idno type="wicri:Area/Ncbi/Curation">002784</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002784</idno>
<idno type="wicri:doubleKey">0885-3185:1990:Miller L:sulpiride:induced:tardive</idno>
<idno type="wicri:Area/Main/Merge">009606</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Sulpiride‐induced tardive dystonia</title>
<author><name sortKey="Miller, Lucinda G" sort="Miller, Lucinda G" uniqKey="Miller L" first="Lucinda G." last="Miller">Lucinda G. Miller</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Family Medicine, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1990">1990</date>
<biblScope unit="vol">5</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="83">83</biblScope>
<biblScope unit="page" to="84">84</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F419D35E0DD2E2934DEA8404678245319EF21ED2</idno>
<idno type="DOI">10.1002/mds.870050119</idno>
<idno type="ArticleID">MDS870050119</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antipsychotic Agents (adverse effects)</term>
<term>Antipsychotic Agents (therapeutic use)</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Dystonia (chemically induced)</term>
<term>Humans</term>
<term>Male</term>
<term>Parkinsonism</term>
<term>Psychotic Disorders (drug therapy)</term>
<term>Receptors, Dopamine (drug effects)</term>
<term>Receptors, Dopamine D2</term>
<term>Sulpiride</term>
<term>Sulpiride (adverse effects)</term>
<term>Sulpiride (therapeutic use)</term>
<term>Tardive dystonia</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Sulpiride</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptors, Dopamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Sulpiride</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Dystonia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Humans</term>
<term>Male</term>
<term>Receptors, Dopamine D2</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sulpiride is a selective D2‐receptor antagonist with antipsychotic and antidepressant properties. Although initially thought to be free of extrapyramidal side effects, sulpiride‐induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a 37‐year‐old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not find any previous reports of sulpiride‐induced tardive dystonia.</div>
</front>
</TEI>
<double doi="10.1002/mds.870050119"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sulpiride‐induced tardive dystonia</title>
<author><name sortKey="Miller, Lucinda G" sort="Miller, Lucinda G" uniqKey="Miller L" first="Lucinda G." last="Miller">Lucinda G. Miller</name>
</author>
<author><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F419D35E0DD2E2934DEA8404678245319EF21ED2</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1002/mds.870050119</idno>
<idno type="url">https://api.istex.fr/document/F419D35E0DD2E2934DEA8404678245319EF21ED2/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003B72</idno>
<idno type="wicri:Area/Istex/Curation">003B72</idno>
<idno type="wicri:Area/Istex/Checkpoint">004361</idno>
<idno type="wicri:doubleKey">0885-3185:1990:Miller L:sulpiride:induced:tardive</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Sulpiride‐induced tardive dystonia</title>
<author><name sortKey="Miller, Lucinda G" sort="Miller, Lucinda G" uniqKey="Miller L" first="Lucinda G." last="Miller">Lucinda G. Miller</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Family Medicine, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1990">1990</date>
<biblScope unit="vol">5</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="83">83</biblScope>
<biblScope unit="page" to="84">84</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F419D35E0DD2E2934DEA8404678245319EF21ED2</idno>
<idno type="DOI">10.1002/mds.870050119</idno>
<idno type="ArticleID">MDS870050119</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinsonism</term>
<term>Sulpiride</term>
<term>Tardive dystonia</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sulpiride is a selective D2‐receptor antagonist with antipsychotic and antidepressant properties. Although initially thought to be free of extrapyramidal side effects, sulpiride‐induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a 37‐year‐old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not find any previous reports of sulpiride‐induced tardive dystonia.</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sulpiride-induced tardive dystonia.</title>
<author><name sortKey="Miller, L G" sort="Miller, L G" uniqKey="Miller L" first="L G" last="Miller">L G Miller</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Family Medicine, Baylor College of Medicine, Houston, Texas 77030.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Family Medicine, Baylor College of Medicine, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Jankovic, J" sort="Jankovic, J" uniqKey="Jankovic J" first="J" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1990">1990</date>
<idno type="RBID">pubmed:1967484</idno>
<idno type="pmid">1967484</idno>
<idno type="doi">10.1002/mds.870050119</idno>
<idno type="wicri:Area/PubMed/Corpus">004F45</idno>
<idno type="wicri:Area/PubMed/Curation">004F45</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004E75</idno>
<idno type="wicri:Area/Ncbi/Merge">002784</idno>
<idno type="wicri:Area/Ncbi/Curation">002784</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002784</idno>
<idno type="wicri:doubleKey">0885-3185:1990:Miller L:sulpiride:induced:tardive</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Sulpiride-induced tardive dystonia.</title>
<author><name sortKey="Miller, L G" sort="Miller, L G" uniqKey="Miller L" first="L G" last="Miller">L G Miller</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Family Medicine, Baylor College of Medicine, Houston, Texas 77030.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Family Medicine, Baylor College of Medicine, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Jankovic, J" sort="Jankovic, J" uniqKey="Jankovic J" first="J" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1990" type="published">1990</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antipsychotic Agents (adverse effects)</term>
<term>Antipsychotic Agents (therapeutic use)</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Dystonia (chemically induced)</term>
<term>Humans</term>
<term>Male</term>
<term>Psychotic Disorders (drug therapy)</term>
<term>Receptors, Dopamine (drug effects)</term>
<term>Receptors, Dopamine D2</term>
<term>Sulpiride (adverse effects)</term>
<term>Sulpiride (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Sulpiride</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptors, Dopamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Sulpiride</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Dystonia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Humans</term>
<term>Male</term>
<term>Receptors, Dopamine D2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties. Although initially thought to be free of extrapyramidal side effects, sulpiride-induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not find any previous reports of sulpiride-induced tardive dystonia.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009606 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 009606 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:F419D35E0DD2E2934DEA8404678245319EF21ED2 |texte= Sulpiride‐induced tardive dystonia }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |